vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Primis Financial Corp. (FRST). Click either name above to swap in a different company.

Primis Financial Corp. is the larger business by last-quarter revenue ($45.6M vs $23.1M, roughly 2.0× ADC Therapeutics SA). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs 13.0%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Primis Financial Corp is a U.S.-based financial holding company operating full-service banking subsidiaries. It provides a comprehensive range of financial solutions including personal and commercial deposit products, diverse loan facilities, mortgage services, and wealth management support, primarily serving retail and corporate customers across the U.S. mid-Atlantic region.

ADCT vs FRST — Head-to-Head

Bigger by revenue
FRST
FRST
2.0× larger
FRST
$45.6M
$23.1M
ADCT
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
13.0%
FRST

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ADCT
ADCT
FRST
FRST
Revenue
$23.1M
$45.6M
Net Profit
$7.3M
Gross Margin
Operating Margin
-77.7%
Net Margin
16.0%
Revenue YoY
36.4%
Net Profit YoY
200.0%
EPS (diluted)
$0.04
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
FRST
FRST
Q1 26
$45.6M
Q4 25
$23.1M
$80.9M
Q3 25
$15.8M
$41.0M
Q2 25
$18.1M
$43.2M
Q1 25
$17.4M
$58.7M
Q4 24
$16.9M
$38.8M
Q3 24
$18.0M
$37.3M
Q2 24
$17.0M
$35.7M
Net Profit
ADCT
ADCT
FRST
FRST
Q1 26
$7.3M
Q4 25
$29.5M
Q3 25
$-41.0M
$6.8M
Q2 25
$-56.6M
$2.4M
Q1 25
$-38.6M
$22.6M
Q4 24
$-26.2M
Q3 24
$-44.0M
$1.2M
Q2 24
$-36.5M
$3.4M
Operating Margin
ADCT
ADCT
FRST
FRST
Q1 26
Q4 25
-77.7%
44.8%
Q3 25
-196.6%
21.3%
Q2 25
-244.1%
6.9%
Q1 25
-163.5%
41.9%
Q4 24
-191.8%
-123.0%
Q3 24
-197.4%
-3.1%
Q2 24
-170.5%
7.8%
Net Margin
ADCT
ADCT
FRST
FRST
Q1 26
16.0%
Q4 25
36.5%
Q3 25
-260.1%
16.7%
Q2 25
-313.2%
5.6%
Q1 25
-221.8%
38.6%
Q4 24
-100.3%
Q3 24
-244.1%
3.3%
Q2 24
-214.6%
9.6%
EPS (diluted)
ADCT
ADCT
FRST
FRST
Q1 26
$0.30
Q4 25
$0.04
$1.19
Q3 25
$-0.30
$0.28
Q2 25
$-0.50
$0.10
Q1 25
$-0.36
$0.92
Q4 24
$-0.26
$-0.95
Q3 24
$-0.42
$0.05
Q2 24
$-0.38
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
FRST
FRST
Cash + ST InvestmentsLiquidity on hand
$261.3M
$159.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$427.2M
Total Assets
$323.1M
$4.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
FRST
FRST
Q1 26
$159.9M
Q4 25
$261.3M
$143.6M
Q3 25
$234.7M
$63.9M
Q2 25
$264.6M
$94.1M
Q1 25
$194.7M
$57.0M
Q4 24
$250.9M
$64.5M
Q3 24
$274.3M
$77.3M
Q2 24
$300.1M
$66.6M
Stockholders' Equity
ADCT
ADCT
FRST
FRST
Q1 26
$427.2M
Q4 25
$-185.8M
$422.9M
Q3 25
$-238.2M
$382.2M
Q2 25
$-199.2M
$376.4M
Q1 25
$-238.2M
$375.6M
Q4 24
$-202.6M
$351.8M
Q3 24
$-171.9M
$381.0M
Q2 24
$-131.7M
$376.0M
Total Assets
ADCT
ADCT
FRST
FRST
Q1 26
$4.3B
Q4 25
$323.1M
$4.0B
Q3 25
$289.8M
$4.0B
Q2 25
$321.6M
$3.9B
Q1 25
$272.5M
$3.7B
Q4 24
$322.0M
$3.7B
Q3 24
$349.1M
$4.0B
Q2 24
$371.8M
$4.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
FRST
FRST
Operating Cash FlowLast quarter
$-31.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
FRST
FRST
Q1 26
Q4 25
$-31.1M
$10.8M
Q3 25
$-29.6M
$-11.4M
Q2 25
$-24.1M
$-41.0M
Q1 25
$-56.3M
$34.4M
Q4 24
$-21.9M
$19.5M
Q3 24
$-25.0M
$6.1M
Q2 24
$-32.8M
$52.3M
Free Cash Flow
ADCT
ADCT
FRST
FRST
Q1 26
Q4 25
$9.0M
Q3 25
Q2 25
Q1 25
$-56.6M
Q4 24
$-21.9M
$18.3M
Q3 24
$-25.3M
Q2 24
$-32.9M
FCF Margin
ADCT
ADCT
FRST
FRST
Q1 26
Q4 25
11.2%
Q3 25
Q2 25
Q1 25
-325.2%
Q4 24
-129.8%
47.3%
Q3 24
-140.2%
Q2 24
-193.0%
Capex Intensity
ADCT
ADCT
FRST
FRST
Q1 26
Q4 25
0.0%
2.1%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
1.5%
Q4 24
0.5%
3.1%
Q3 24
1.2%
0.0%
Q2 24
0.2%
0.0%
Cash Conversion
ADCT
ADCT
FRST
FRST
Q1 26
Q4 25
0.36×
Q3 25
-1.67×
Q2 25
-16.82×
Q1 25
1.52×
Q4 24
Q3 24
4.93×
Q2 24
15.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

FRST
FRST

Net Interest Income$32.1M70%
Noninterest Income$13.6M30%

Related Comparisons